Literature DB >> 23156071

Biosimilars might not measure up to health plan expectations.

Tom Reinke.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23156071

Source DB:  PubMed          Journal:  Manag Care        ISSN： 1062-3388


× No keyword cloud information.
  4 in total

1.  Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees.

Authors:  C Lee Ventola
Journal:  P T       Date:  2015-10

2.  Biosimilars: part 2: potential concerns and challenges for p&t committees.

Authors:  C Lee Ventola
Journal:  P T       Date:  2013-06

3.  Biosimilars: part 1: proposed regulatory criteria for FDA approval.

Authors:  C Lee Ventola
Journal:  P T       Date:  2013-05

Review 4.  Biosimilar insulins: guidance for data interpretation by clinicians and users.

Authors:  L Heinemann; P D Home; M Hompesch
Journal:  Diabetes Obes Metab       Date:  2015-07-01       Impact factor: 6.577
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.